Breast Cancer Res Treat. 2014 Feb;144(1):103-11. doi: 10.1007/s10549-013-2830-5. Epub 2014 Jan 28.7
Drukker C.A., Schmidt M.K., Rutgers E.J., Cardoso F., Kerlikowske K., Esserman L.J., van Leeuwen F.E., Pijnappel R.M., Slaets L., Bogaerts J., Van’t Veer L.J.
Among the screen-detected cancers, 32 % had a 70-gene signature high-risk and 68 % a low-risk tumor, of which 54 % had a ultralow-risk tumor (37 % of total) (Fig. 1a; Table 1). Among the interval cancers, 47 % had a high-risk and 53 % a low-risk tumor, of which 46 % could be defined as ultralow-risk tumor (24 % of total).
Read more: Mammographic Screening Detects Low-Risk…Drukker_Breast Cancer Res Treat. 2014